These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 8923032)

  • 1. Mechanistic considerations in the evaluation of chemopreventive data.
    Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet RA; Greenwald P; Hawk ET; Fay JR; Sigman CC
    IARC Sci Publ; 1996; (139):203-19. PubMed ID: 8923032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic considerations in chemopreventive drug development.
    Kelloff GJ; Boone CW; Steele VE; Fay JR; Lubet RA; Crowell JA; Sigman CC
    J Cell Biochem Suppl; 1994; 20():1-24. PubMed ID: 7616736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk biomarkers and current strategies for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preventive medicine: biomonitoring and chemoprevention].
    Tompa A; Szende B
    Magy Onkol; 2002; 46(2):147-53. PubMed ID: 12202894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surrogate endpoint biomarkers for phase II cancer chemoprevention trials.
    Kelloff GJ; Boone CW; Crowell JA; Steele VE; Lubet R; Doody LA
    J Cell Biochem Suppl; 1994; 19():1-9. PubMed ID: 7823579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials.
    Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet R; Sigman CC
    Cancer Res; 1994 Apr; 54(7 Suppl):2015s-2024s. PubMed ID: 8137331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surrogate end-point biomarkers in chemopreventive drug development.
    Kelloff GJ; Sigman CC; Hawk ET; Johnson KM; Crowell JA; Guyton KZ
    IARC Sci Publ; 2001; 154():13-26. PubMed ID: 11220652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of chemoprevention in cancer control.
    Greenwald P; Kelloff GJ
    IARC Sci Publ; 1996; (139):13-22. PubMed ID: 8923016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micronutrients as chemopreventive agents.
    Reddy BS
    IARC Sci Publ; 1996; (139):221-35. PubMed ID: 8923033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of mechanisms of cancer chemopreventive agents.
    De Flora S; Ferguson LR
    Mutat Res; 2005 Dec; 591(1-2):8-15. PubMed ID: 16107270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of chemopreventive agents in different mechanistic classes using a rat tracheal epithelial cell culture transformation assay.
    Arnold JT; Wilkinson BP; Sharma S; Steele VE
    Cancer Res; 1995 Feb; 55(3):537-43. PubMed ID: 7834622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in clinical chemoprevention.
    Kelloff GJ; Hawk ET; Karp JE; Crowell JA; Boone CW; Steele VE; Lubet RA; Sigman CC
    Semin Oncol; 1997 Apr; 24(2):241-52. PubMed ID: 9129692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpretation of short-term test data: implications for assessment of chemopreventive activity.
    Waters MD; Stack HF; Jackson MA; Brockman HE
    IARC Sci Publ; 1996; (139):313-32. PubMed ID: 8923041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer chemoprevention by phytochemicals: potential molecular targets, biomarkers and animal models.
    Kwon KH; Barve A; Yu S; Huang MT; Kong AN
    Acta Pharmacol Sin; 2007 Sep; 28(9):1409-21. PubMed ID: 17723174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data evaluation as a contribution to cancer prevention.
    Stewart BW
    IARC Sci Publ; 1996; (139):303-12. PubMed ID: 8923040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer chemoprevention with garlic and its constituents.
    Shukla Y; Kalra N
    Cancer Lett; 2007 Mar; 247(2):167-81. PubMed ID: 16793203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemoprevention of cancer. Prevention of cancer in groups with increased risk].
    Sanner T; Dybing E
    Tidsskr Nor Laegeforen; 1996 Aug; 116(19):2329-33. PubMed ID: 8804210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
    Meyskens FL; Gerner EW
    Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of DNA adduct formation in liver and mammary epithelial cells of rats treated with 7,12-dimethylbenz(a)anthracene, and selective effects of chemopreventive agents.
    Izzotti A; Camoirano A; Cartiglia C; Grubbs CJ; Lubet RA; Kelloff GJ; De Flora S
    Cancer Res; 1999 Sep; 59(17):4285-90. PubMed ID: 10485473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.